Local anesthesia with epinephrine is safe and effective for oral surgery in patients with type 2 diabetes mellitus and coronary disease: a prospective randomized study by Santos-Paul, Marcela Alves dos et al.
Local anesthesia with epinephrine is safe and
effective for oral surgery in patients with type 2
diabetes mellitus and coronary disease: a prospective
randomized study
Marcela Alves dos Santos-Paul,I* Itamara Lucia Itagiba Neves,I Ricardo Simo˜es Neves,I
Jose´ Antonio Franchini RamiresII
IHeart Institute (InCor) do Hospital das Clı´nicas da Faculdade de Medicina da Universidade de Sa˜o Paulo, Dental Unit, Sa˜o Paulo, Brazil. IIHospital das
Clı´nicas da Faculdade de Medicina da Universidade de Sa˜o Paulo, Department of Cardiology, Sa˜o Paulo, Brazil.
OBJECTIVE: To investigate the variations in blood glucose levels, hemodynamic effects and patient anxiety
scores during tooth extraction in patients with type 2 diabetes mellitus T2DM and coronary disease under local
anesthesia with 2% lidocaine with or without epinephrine.
STUDY DESIGN: This is a prospective randomized study of 70 patients with T2DM with coronary disease who
underwent oral surgery. The study was double blind with respect to the glycemia measurements. Blood glucose
levels were continuously monitored for 24 hours using the MiniMed Continuous Glucose Monitoring System.
Patients were randomized into two groups: 35 patients received 5.4 mL of 2% lidocaine, and 35 patients
received 5.4 mL of 2% lidocaine with 1:100,000 epinephrine. Hemodynamic parameters (blood pressure and
heart rate) and anxiety levels were also evaluated.
RESULTS: There was no difference in blood glucose levels between the groups at each time point evaluated.
Surprisingly, both groups demonstrated a significant decrease in blood glucose levels over time. The groups
showed no significant differences in hemodynamic and anxiety status parameters.
CONCLUSION: The administration of 5.4 mL of 2% lidocaine with epinephrine neither caused hyperglycemia
nor had any significant impact on hemodynamic or anxiety parameters. However, lower blood glucose levels
were observed. This is the first report using continuous blood glucose monitoring to show the benefits and lack
of side effects of local anesthesia with epinephrine in patients with type 2 diabetes mellitus and coronary
disease.
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& INTRODUCTION
Diabetes mellitus (DM) is recognized as a worldwide
epidemic, and the rate of type 2 diabetes mellitus T2DM is
increasing. T2DM is a chronic disease that occurs when the
pancreas does not produce enough insulin or cannot act
effectively. In type 1 diabetes, there is a serious lack of
insulin production. Furthermore, insulin resistance occurs
because the insulin receptors are not adequately function-
ing. Persistent hyperglycemia leads to serious damage to
target organs, as well as to oral manifestations due to
microvascular abnormalities. Thus, the prevalence and
severity of periodontal diseases are greater in individuals
with diabetes, and these patients must frequently undergo
invasive oral procedures. However, there is no established
protocol for these procedures in the literature (1-5). In these
cases, oral surgery requires special precautions, such as
stress control and the use of a safe and effective anesthetic
solution. Endogenous catecholamine secreted during psy-
chological stress can lead to an undesirable increase of the
heart rate, blood pressure, and blood glucose level (6-8). In
addition, there is no consensus regarding the safety of local
anesthetic solutions. The inclusion of vasoconstrictors in
local anesthetic solutions offers unquestionable advantages.
Vasoconstrictors promote longer-lasting anesthesia, reduce
the toxic effects by delaying the absorption of anesthetics and
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reduce local bleeding (9,10). Epinephrine is the most
commonly used vasoconstrictor. There is controversy regard-
ing whether epinephrine, as a local anesthetic vasoconstric-
tor, causes adverse hemodynamic effects in cardiac patients
(11-19). Furthermore, this agent has been reported to be
problematic with regard to hyperglycemic effects. Therefore,
some authors recommend the use of epinephrine-free local
anesthetics for T2DM patients (20-22). However, other
authors conclude that epinephrine vasoconstriction is not
contraindicated in patients with T2DM (23,24). Therefore, the
aim of this study was to investigate variations in blood
glucose levels, hemodynamic parameters, and anxiety levels
during tooth extraction under local anesthesia with plain 2%
lidocaine versus 2% lidocaine with 1:100,000 epinephrine in
patients with T2DM and coronary disease.
& PATIENTS AND METHODS
This prospective randomized study was conducted from
September 2009 to November 2012 in patients with T2DM
and coronary disease from the Heart Institute (InCor) of
Hospital das Clı´nicas da Faculdade de Medicina da
Universidade de Sa˜o Paulo (HCFMUSP). The study was
approved by the local ethics committee under the protocol
no 1033/08, and informed consent was obtained from all
patients before inclusion in the study. This study was
registered at clinicaltrials.gov (NCT02173067).
We enrolled adult patients with pharmacologically con-
trolled T2DM (via the use of insulin and/or hypoglycemic
agents) and coronary disease who needed to have at least
one posterior maxillary tooth extracted according to an oral
examination and panoramic radiography.
To assess the levels of blood glucose, the MiniMed
Continuous Glucose Monitoring (CGMS, Medtronic
Diabetes) was employed. This device is able to monitor
average glucose measurements taken every 5 minutes. The
MiniMed monitor was installed in the morning on the day
before the surgery. The patient then went home and
returned to the hospital for the surgery 24 hours later. The
same dentist carried out the surgery in all patients and was
not provided any information regarding the blood glucose
levels of the patients during the protocol. Therefore, in this
sense, the study was double blind. Subjects were randomly
divided into 2 groups: the LCA group received 2% lidocaine
with 1:100,000 epinephrine, and the LSA group received
plain 2% lidocaine. The same volume of anesthetic (5.4 mL)
was applied using a standard technique (25). The MiniMed
monitor was removed an hour after the surgery, and the
data were downloaded into a computer using vMonGluco
Client software.
Standardized times and periods evaluated. T0 (first
value recorded by the MiniMed), T1 (1 hour before the
procedure), T2 (5 minutes before the procedure), T3 (after
anesthesia injection), T4 (end of procedure), and T5 (1 hour
after the procedure). We considered the basal period (BP) to
be from T0 to T1 and the procedure period (PP) to be from
T1 to T5.
The systolic blood pressure (SBP), diastolic blood pres-
sure (DBP) and heart rate (HR) were recorded by an
automatic sphygmomanometer (Microlife APA-P00001) at
T1, T2, T3, and T5.
The anxiety level was measured by the Buchanan and
Niven (26) facial scale at T1, T2, and T5.
If the extracted tooth was a potential source of infection, 500
mg of amoxicillin was prescribed to be taken every 8 hours for
7 days; 300 mg of clindamycin was prescribed to amoxicillin-
allergic individuals. For cases with a high or moderate risk of
infective endocarditis, according to recommendations by the
American Heart Association (27), a single dose of 2 g of
amoxicillin was administered before the procedure. Patients
were instructed to maintain their current medications,
including oral anticoagulants and antiplatelet agents.
Statistical Analysis
Data are presented as the mean¡ standard deviation for
normally distributed data and as the median and range for
non-normally distributed data. To compare means between
the 2 groups, we used t tests; when the assumption of
normality of the data was rejected, we used the nonpara-
metric Mann-Whitney U test. Analysis of variance (ANOVA)
for repeated measurements was performed to compare the
groups according to the times and periods of study (28). A p
value ,0.05 was considered significant.
& RESULTS
A total of 400 patients were initially evaluated. Among
these individuals, 179 were edentulous patients, 74 were
partial edentulous patients, 46 did not require tooth
extraction, and 28 refused to participate, all of whom were
excluded. The remaining 70 patients (50 male, 20 female)
were included (mean age, 63.4¡8.3 years (44-83), body mass
index, 28.0¡5.0 kg/m2).
The subjects were randomly divided into 2 groups: an LSA
group (n=35) and an LCA group (n=35). Table 1 shows the
clinical characteristics of the 2 groups. There was no difference
in gender between the groups (p=0.290). Prophylactic
antibiotics were administered to 3 patients, with no difference
between groups (p=1.000). Amoxicillin was administered
over 7 days to 30 subjects, and clindamycin was administered
to 1 individual; there was no significant difference between the
LSA and LCA groups for this parameter (p=0.336). There was
also no significant difference between the groups (p=0.207)
according to the duration of the surgery.
Blood Glucose Levels
There was no significant difference in the blood glucose
levels during either period between the two groups (Fig 1).
There was also no significant difference in the mean blood
glucose levels in the LSA and LCA groups at any time
(p=0.748). Surprisingly, both groups demonstrated a signifi-
cant decrease in bloodglucose levels (p,0.001) over time (Fig 2).
All participants used oral hypoglycemic drugs and/or
insulin therapy. There were 20 patients in the LSA group and
17 in the LCA group who were receiving insulin therapy,
with no difference between the groups (p= 0.473). Figure 3
illustrates the blood glucose analysis in 4 subgroups with
respect to the use of insulin during the trial interval. There
was no significant difference between the subgroups
(p= 0.737).
Blood Pressure, Heart Rate, and Anxiety Levels
Figures 4 and 5 show that there were no significant
differences in the SBP (p= 0.176), DBP (p= 0.913), and HR
(p= 0.570) between the groups at T1, T2, T3, or T5.
The anxiety level in the LSA and LCA groups did not
significantly change over time (T1, p = 0.953; T2, p = 0.954;
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and T5, p = 0.823). We observed a significant decrease in the
anxiety level (p,0.001) at T1, T2 and T5.
& DISCUSSION
This study assessed the variations in blood glucose levels
in patients with T2DM and coronary disease who required
oral surgery using plain 2% lidocaine or 2% lidocaine with
1:100,000 epinephrine. There was no significant difference in
the blood glucose levels between the LSA and LCA groups.
Surprisingly, a significant decrease in the blood glucose
level was observed over time in both groups. This finding
must be further explored.
Bortoluzzi et al (29) did not verify changes in blood
glucose levels in healthy patients. However, the anesthetic
solution used was different (2% mepivacaine with adrena-
line) and was at a lower dosage than that used in the present
study (2 6 3 cartridges). Tily and Thomas (30) found the
same results in the healthy and diabetic groups regardless
of the applied volume. According to Shcaira et al (31), there
was a difference (p = 0.00003) in blood glucose levels
between the diabetic and healthy groups, with higher
values in the diabetic group. Most authors recommend the
use of epinephrine-free anesthetics for T2DM patients (20-
22). Meechan (32) detected a significant increase in glucose
values during oral surgery when using epinephrine. In
addition, Meechan and Welbury (33) noted an increase in
blood glucose levels in 20 patients undergoing oral surgery
with intravenous midazolam. This increase was observed
only in the group that was receiving 4.4 mL of lidocaine
with 1:80,000 epinephrine. Nakamura et al (34) found
relevant elevations in blood glucose levels after local
anesthesia with epinephrine. Kalra et al (35) observed a
significant increase in blood glucose levels when comparing
diabetic and healthy groups (p,0.005) 20 minutes following
the injection of lidocaine with epinephrine. Our study
shows that the findings of above studies are not definitive;
the discrepancy might be attributed to differences in the
patient characteristics and the methods used to evaluated
the variances. However, this study is more reliable because
the blood glucose levels were continuously monitored.
In this study, all patients had pharmacologically con-
trolled T2DM with coronary disease and hypertension.
Moreover, the blood glucose measurement methods were
different; the above-mentioned studies used a glucose meter
or drew blood samples at predetermined times, whereas our
study was the first to perform continuous glucose monitor-
ing from 24 hours before surgery to 1 hour after surgery,
with the mean glucose levels recorded every 5 minutes.
Specifically, an average of 30 glucose readings were
obtained for each subject only during the surgery.
Therefore, our results seem to be more accurate.
Nevertheless, we took care to standardize the anesthetic
technique and the volumes applied; this choice provides
greater credibility to our results. The volume of 5.4 mL was
selected based on the experience of the InCor Dentistry
Unit, which routinely uses plain lidocaine in patients with
cardiovascular disease. Notably, both of the anesthetic
regimens (LSA and LCA) were effective and did not require
supplementation in either group. Additionally, our results
show a significant decrease in blood glucose levels
(p,0.001) over the study period. The levels at T1 were
Table 1 - Age, body mass index, length of diabetes, glycosylated hemoglobin, time of insulin use in each group.
Clinical characteristics (mean ¡ standard deviation) Groups p
LSA (n =35) LCA (n=35)
Age (years) 62.2¡7.7 64.7¡8.8 0.21
BMI (kg/m2) 27.7¡4.9 28.3¡4.3 0.59
Length of diabetes (years) 14.8¡10.4 13.5¡8.9 0.58
HbA1c (%) 7.8¡1.8 7.5¡1.9 0.48
Length of insulin use (years) 7.5¡7.1 7.3¡7.5 0.95
*LSA = plain 2% lidocaine; LCA = 2% lidocaine with 1:100.000 epinephrine; BMI = body mass index; HbA1c = glycosylated hemoglobin
Figure 1 - Means of blood glucose levels in basal period (PB) and
procedural period (PP) in LSA and LCA group.
Figure 2 - Means of blood glucose levels in time in LSA and LCA
group.
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significantly different compared with those at T2 (p = 0.003),
T3 (p,0.001), T4 (p,0.001), and T5 (p,0.001). This
observation has not been previously described in the
literature.
All participants used oral hypoglycemic drugs and/or
insulin therapy. Medications were not suspended, and their
doses were not changed to accommodate the oral surgery.
Oral anticoagulant and antiplatelet agents were maintained,
although some authors have suggested suspending them
(36).
We also evaluated the hemodynamic effects (BP and HR)
and anxiety levels of the patients. The use of epinephrine as
a local anesthetic for cardiac patients is controversial. Most
studies have shown adverse hemodynamic effects (16-18),
whereas other authors recommend a maximum dose of 0.04
mg (23).
In the present study, there were no differences between
groups in the SBP (p= 0.176), DBP (p= 0.913) and HR
(p= 0.570). These results corroborate those of a study by
Neves et al (37) that used 1.8 mL or 3.6 mL of plain lidocaine
and lidocaine with 1:100,000 epinephrine prior to proce-
dures on coronary patients. These findings are also in
accordance with those of Conrado et al (38), who compared
patients undergoing dental extraction with 3% mepivacaine
and 2% mepivacaine with 1:100,000 epinephrine. Takahashi
et al (39) investigated the influence of varying concentra-
tions of exogenous epinephrine combined with a local
anesthetic on endogenous plasma catecholamine levels and
did not observe a significant difference in SBP, DBP, and HR
among groups. A study by Meral et al (10) used the same
anesthetic solution that we used but at a lower volume (2.0
mL of plain lidocaine with 1:100,000 epinephrine). These
subjects also underwent extractions, although they were
otherwise healthy. There were no significant differences in
the BP. With respect to the HR, the authors reported a
significant increase in both groups, which differed from the
findings of our study. We can attribute our results to the
level of anesthetic used due to the time required to
administer the local anesthesia.
Anxiety and fear are common during oral procedures.
Psychological stress can lead to adverse cardiovascular and
metabolic effects. The use of a vasoconstrictor in a local
anesthetic solution promotes longer-lasting anesthesia and
likely decreases stress (9,10). For this reason, many
researchers have their subjects undergo conscious sedation
or general anesthesia to compare local anesthetic solutions
(31-33). We performed the surgeries in a private dental care
office without any sedation. Our results show that the
anxiety levels did not significantly change in the LSA and
LCA groups during oral surgery.
The results observed in this study allow us to conclude that
oral surgery performed in an outpatient clinic on patients
with diabetes and coronary disease using local anesthesia at
the assessed volume (5.4 mL) is safe, regardless of whether
epinephrine (1:100,000) is included. Furthermore, the use of
epinephrine does not interfere with blood glucose levels,
hemodynamic parameters, or the emotional state. In contrast,
we observed lower glucose blood levels when epinephrine
was included in the anesthetic solution.
This study contributes to dental practice in unique and
severe cases by providing scientific support for surgical
procedures in patients with diabetes and coronary disease.
Furthermore, it clarifies the theory that the use of
epinephrine in combination with anesthetics not increases
the risk of hyperglycemia and hemodynamic repercussions.
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